Skip to content

The Impact of "Specimen Point Matching" Electroacupuncture Therapy on ERAS in Endoscopic Rectal Cancer Surgery under General Anesthesia

The Impact of "Specimen Point Matching" Electroacupuncture Therapy on ERAS in Endoscopic Rectal Cancer Surgery under General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000750
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

control group:General anesthesia with combined intravenous and inhalation anesthesia + sham electroacupuncture
Experimental group:General anesthesia with combined intravenous and inhalation anesthesia + electroacupuncture

Sponsors

Department of Anesthesiology of the Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University(Guangzhou Key Medical Discipline)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) First-time undergoing endoscopic surgery for rectal cancer; (2) No gender restrictions, age = 18 years old; (3) American Society of Anesthesiologists (ASA) classification I-III; (4) Intraoperative anesthesia method is tracheal intubation general anesthesia; (5) Able to understand the Numerical Rating Scale (NRS), anxiety scale, depression scale, and pain catastrophizing scale; (6) Voluntary participation, with informed consent signed by the patient or their family, and included in the clinical ethics treatment of patients.

Exclusion criteria

Exclusion criteria: (1) The patient does not agree to participate in the study or surgery and has not signed the informed consent form. (2) Those with severe cardiovascular system diseases or chronic respiratory diseases such as COPD, etc. (3) Those with a history of stroke or transient ischemic attack. (4) Those with a history of allergy to the analgesic drugs used in this study. (5) Those with a history of drug addiction. (6) Those currently taking antidepressants or sedatives, etc. (7) Those with central nervous system diseases.

Design outcomes

Primary

MeasureTime frame
TNF-a;PGE2;Numerical Rating Scale;

Secondary

MeasureTime frame
Pain Catastrophizing Scale score;Depression Scale;Anxiety Scale;Quality of life score;

Countries

China

Contacts

Public ContactLu Yi

The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University

Louis0731@qq.com13826495169

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026